Sandeep Chandrashekharappa

Title: Innovations of Sandeep Chandrashekharappa

Introduction

Sandeep Chandrashekharappa is a notable inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target adenosine receptors. His work has implications for treating various medical conditions, including inflammation and cancer.

Latest Patents

Chandrashekharappa holds a patent for "7-isopropyl 1,2-dimethyl 3-(substituted benzoyl)indolizine-1,2,7-tricarboxylates as adenosine receptor active compounds." This patent encompasses novel compounds, methods of synthesizing these compounds, and their pharmaceutical applications. The compounds identified as adenosine A receptor (AAR) modulators are useful in treating conditions such as rheumatoid arthritis, psoriasis, and fatty liver diseases, among others.

Career Highlights

He is currently affiliated with King Fahd University of Petroleum and Minerals, where he continues to advance his research in pharmaceutical sciences. His innovative work has garnered attention in the scientific community, contributing to the understanding of adenosine-related conditions.

Collaborations

Chandrashekharappa has collaborated with esteemed colleagues, including Katharigatta N Venugopala and Pran Kishore Deb, to further his research endeavors. Their combined expertise enhances the potential impact of their work in the field.

Conclusion

Sandeep Chandrashekharappa's contributions to pharmaceutical chemistry and his innovative patent highlight the importance of research in developing new treatments for complex medical conditions. His work exemplifies the role of inventors in advancing healthcare solutions.